Ma, David Hui-Kang http://orcid.org/0000-0003-1847-8961
Hsueh, Yi-Jen
Ma, Kevin Sheng-Kai
Tsai, Yueh-Ju
Huang, Shiang-Fu
Chen, Hung-Chi
Sun, Chi-Chin
Kuo, Ming-Tse
Chao, An-Shine
Lai, Jui-Yang
Clinical trials referenced in this document:
Documents that mention this clinical trial
Long-term survival of cultivated oral mucosal epithelial cells in human cornea: generating cell sheets using an animal product-free culture protocol
https://doi.org/10.1186/s13287-021-02564-7
Funding for this research was provided by:
ministry of science and technology, taiwan (107-2314-B-182A-122, 108-2314-B-182A-114)
chang gung memorial hospital, linkou (CPRPG1J0011)
Article History
Received: 4 August 2021
Accepted: 20 August 2021
First Online: 7 October 2021
Declarations
:
: The clinical trial was approved by the Institutional Review Board of Chang Gung Memorial Hospital (Registry Number 98-2148B). The study was further approved by Taiwan’s Food and Drug Administration (TFDA) and was executed under its supervision as a Phase Ib clinical trial (Registry Number 0950206914). This ongoing study is also registered in ClinicalTrials.gov (ID NCT03943797). Written informed consent was obtained from all AM donors, oral mucosa donors, and clinical trial patients.
: Institutional consent form has been signed by the patients.
: DH-KM is the inventor of US patent “Method for the ex vivo cultivation of oral mucosal epithelial progenitor cells and oral mucosal epithelial cells” (Patent No.: 10.415,014 B2). Chang Gung Memorial Hospital, Linkou, Taoyuan (TW) is the patent applicant. Other co-authors declared no competing interests.